Navigation Links
Access Pharmaceuticals MuGard Added to Nationally Ranked Children's Hospital of Colorado Pharmacy Formulary
Date:2/16/2012

DALLAS and NEW YORK, Feb. 16, 2012 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that Children's Hospital of Colorado has added MuGard to its hospital pharmacy formulary.  Children and young adults undergoing cancer treatment will now have direct access to MuGard from the first day of cancer treatment to manage oral mucositis, characterized by inflammation and erythema or ulcerations throughout the oral mucosa.

Commenting on the significance of the event, Frank Jacobucci, Vice President Sales and Marketing, Access Pharmaceuticals, Inc. said, "Having Children's Hospital of Colorado evaluate MuGard and determine that it has tremendous benefit for their patients undergoing cancer therapy is an important milestone for Access.  There are roughly 5800 hospitals in the US with approximately 37 million admissions annually.  The hospital inpatient market is very large and currently there is no meaningful intervention for these patients to prevent or treat oral mucositis. The inclusion of MuGard on Children's Hospital formulary will allow providers and patients to have access to MuGard and potentially eliminate oral mucositis as a side effect of anticancer treatment regimens."

Top ranked consecutively on the U.S. News & World Report Best Children's Hospital's honor rankings since inception, Children's Hospital Colorado garners local, regional, national and international respect for its treatment and care of children, adolescents and young adults with cancer and non-malignant blood diseases, such as hemophilia and sickle cell anemia. The Center is the o
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  Novastem, a ... its first patient in its study for ischemic ... American Stroke Association, ischemic strokes account for 87 ... enroll qualified patients in the study, entitled "Internal ... of Allogeneic Mesenchymal Stem Cells and Intrathecal Administration ...
(Date:12/24/2014)... BUFFALO, N.Y. , Dec. 24, 2014 ... been dosed with KX2-361 at Roswell Park Cancer Institute. ... a small molecule drug that has shown potent inhibitory ... lines, including those that are resistant to Temozolomide (T98G), ... malignant glioma. In a well-established brain tumor mouse model, ...
(Date:12/24/2014)... 2014  Diplomat Pharmacy, Inc. (NYSE: DPLO ... to announce Jennifer Hagerman , Pharm.D., AE-C, senior ... office as the president of the Michigan Pharmacists Association ... take place Feb. 28, 2015, at the MPA Annual ... Renaissance Center in Detroit, Michigan . ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3
... most commonly used proton pump inhibitors raise risk of ... and increase healthcare costs - Drug interaction increases annual ... May 6 Four of the most commonly prescribed ... widely used antiplatelet medication also known by its brand ...
... May Issue of Journal of Sexual Medicine INDIANAPOLIS, May ... LLY ) today announced results from a double-blind, placebo-controlled ... once daily was generally well-tolerated, improved erectile function for ... the sexual quality of life scores for men and ...
Cached Medicine Technology:New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug 2New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug 3New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug 4Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 2Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 3Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 4Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 5
(Date:12/25/2014)... (PRWEB) December 26, 2014 The ... CAGR of 7.2% to reach $5,756.0 million by ... the microscopy market. The electron microscopes product segment ... the forecast period. , Rising focus on nanotechnology, ... growth of the microscopy market. , Get Full ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 ... BambooFlooringChina.com combines beauty, strength and durability. Today, the ... promotion, which is valid until Jan. 30, 2015. ... grain of traditional hardwood. BambooFlooringChina.com is a well-known ... help consumers worldwide to find a reliable bamboo ...
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... Analysis to 2023” focuses on the current treatment landscape, ... colorectal cancer market. TS-1 is an anti-cancer drug which ... administered orally and is also used for treating gastric ... gimestat and otastat potassium. The drug was first approved ...
(Date:12/25/2014)... 2014 “Every three months the trends for ... sweetheart evening dress will be one of the hottest styles ... Yunx.co.uk says. Today, the company releases 26 A-line sweetheart evening ... 80% off. , “We are trying our best to ... our latest designs. Along with affordable prices, we provide discounted ...
(Date:12/25/2014)... December 26, 2014 Recently, Dylan Queen, ... has excitedly released its collection of discounted prom dresses, ... Percy, a senior spokesman of the company, the promotion ... this promotion is to expand the UK market. , ... several different colors, lengths, and styles: A-line strapless, empire ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... ... shortage , ... September 26, 2009 -- A discussion about the nursing shortage in Oregon will be among ... at a seminar hosted by George Fox University on Thursday, Oct. 15., , , , ...
... University study found that a family, school and community intervention ... new tool in the fight against the nation,s childhood obesity ... Switch program -- a program developed by the Minneapolis-based National ... average of two fewer hours of television and also consumed ...
... Toxin from the deadly Brazilian wandering spider may improve ... -- Scientists may have discovered a novel way to ... deadly spider. , The bite from the Brazilian wandering ... last for many hours and later lead to impotence, ...
... Georgia State University have uncovered the mechanisms of how ... in adulthood. Research is now indicating that ... unit (NICU) show altered pain sensitivity in adolescence. These ... pre-emptive and post-operative pain medicine for newborn infants. ...
... School of Medicine (BUSM) in collaboration with researchers ... androgen deficiency might be the underlying cause for ... erectile dysfunction, metabolic syndrome and cardiovascular disease (CVD). ... the Journal of Andrology . Androgens ...
... with results in a day , FRIDAY, Sept. 25 (HealthDay ... in people who,ve had negative sputum tests, say European researchers. ... the disease-causing bacterium can,t be identified using sputum tests. Because ... the spread of TB, the researchers said. , "In this ...
Cached Medicine News:Health News:George Fox University Hosts Oregon Center for Nursing Director Oct. 15 2Health News:Study finds intervention program increases kids' healthy eating, reduces screen time 2Health News:Spider Venom -- The Next Way to Treat Impotence? 2Health News:Infant pain, adult repercussions 2Health News:Infant pain, adult repercussions 3Health News:BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease 2Health News:Faster Detection of TB May Be on the Horizon 2
The HYRYS™ 2 densitometer is reflective of Sebia's expertise in the development and design of imaging systems and densitometers utilized in the electrophoresis field....
Hydragel K20 is Sebia's quality line of manual agarose gel electrophoresis products. Samples are applied utilizing the same patented applicator combs that is used for sample application on the HYDRAS...
Eliminating the need for any manual pipetting, the HydraPLUS delivers precise micro-volumes of sample directly from primary tubes to four HYDRASYS sample applicators contained in a built-in humidity ...
Handheld Digital Retinal Camera...
Medicine Products: